TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 61 filers reported holding TRANSLATE BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 1,872,115 | $30,871,000 | 5.70% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $35,994,000 | 2.89% |
| Baupost Group | 18,044,239 | $295,810,000 | 2.36% |
| RTW INVESTMENTS, LP | 4,382,199 | $72,262,000 | 1.13% |
| DAFNA Capital Management LLC | 225,393 | $3,717,000 | 0.88% |
| Camber Capital Management LP | 1,150,000 | $18,964,000 | 0.65% |
| EcoR1 Capital, LLC | 596,900 | $9,843,000 | 0.44% |
| Alpha Paradigm Partners, LLC | 50,393 | $831,000,000 | 0.32% |
| Birchview Capital, LP | 30,000 | $495,000 | 0.29% |
| Artal Group S.A. | 1,000,000 | $16,490,000 | 0.29% |